The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The prognostic value of tumor markers in patients (pts) with resectable gastric cancer (GC) receiving perioperative therapy in the CRITICS trial.
 
Astrid E. Slagter
No Relationships to Disclose
 
Marieke A. Vollebergh
No Relationships to Disclose
 
Irene A Caspers
No Relationships to Disclose
 
Johanna W. van Sandick
No Relationships to Disclose
 
Karolina Sikorska
No Relationships to Disclose
 
Pehr A. Lind
No Relationships to Disclose
 
Marianne Nordsmark
No Relationships to Disclose
 
Hein Putter
No Relationships to Disclose
 
Jeffrey P.B.M. Braak
No Relationships to Disclose
 
Elma Meershoek – Klein Kranenbarg
No Relationships to Disclose
 
Cornelis J.H. Van De Velde
No Relationships to Disclose
 
Edwin PM Jansen
Research Funding - Roche (Inst)
 
Annemieke Cats
No Relationships to Disclose
 
Hanneke W.M. Van Laarhoven
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly/ImClone; Nordic Group; Servier
Research Funding - Bayer Schering Pharma (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Janssen-Cilag (Inst); Lilly (Inst); Merck KGaA (Inst); Merck Sharp & Dohme (Inst); Nordic Group (Inst); Philips Healthcare (Inst); Roche (Inst); Servier (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Nicole C.T. van Grieken
Consulting or Advisory Role - BMS (Inst); Merck (Inst)
 
Marcel Verheij
Research Funding - Roche (Inst)